Sign in

Pete Manza

@petemanza.bsky.social
315 followers 198 following 9 posts

Clinical neuroscientist testing new therapies for addiction! Assistant Prof., Kahlert Institute for Addiction Medicine, U Maryland School of Medicine

PostsRepliesMedia
Reposted by Pete Manza
Renata Marchette @renatamarchette.bsky.social · 07/02/2026
Our work characterizing the respiratory depression caused by opioids and alcohols is finally out in the world! pubmed.ncbi.nlm.nih.gov/41632547/
pubmed.ncbi.nlm.nih.gov
Potentiation of fentanyl-induced respiratory depression by alcohol is not fully reversed by naloxone - PubMed
The high frequency of opioid overdose deaths often involves co-use of alcohol, which is reported in approximately 30% of fentanyl fatalities. Both substances depress respiratory function, and their combined effects can be lethal. The present study investigated physiological parameters of respiratory …
1156
Reposted by Pete Manza
Kahlert Institute for Addiction Medicine @kahlertumsom.bsky.social · 05/01/2026
🧠🎙️ Assistant Professor @petemanza.bsky.social was recently featured in @npr.org, discussing a "mindset shift about what stimulants are doing for people" and how we understand ADHD medications. Explore the full story and Dr. Manza’s insights here: www.npr.org/sections/sho.... #InTheNews #ICYMI
011
Reposted by Pete Manza
Kahlert Institute for Addiction Medicine @kahlertumsom.bsky.social · 25/09/2025
🆕 @petemanza.bsky.social, Mimi Belcher and Sarah Kattakuzhy are among the authors of a study published in @ajdaajournal.bsky.social that shows promising results for using ketamine to treat #OUD in patients w/ co-occurring depression. 🔗 Learn more: www.tandfonline.com/doi/full/10.... #AddictionSci
Graphic describing study with researchers' headshotsGraphic describing studyGraphic describing study with chartGraphic describing study
133
Reposted by Pete Manza
Kahlert Institute for Addiction Medicine @kahlertumsom.bsky.social · 20/08/2025
In this #MeetTheMinds, we're introducing you to Community Advisor Ernie Graham! Ernie is instrumental in raising public awareness around our mission. Here's a slam-dunk fact about Ernie: he's a University of Maryland basketball legend! 🏀 Visit addiction.umaryland.edu for more.
Introduction to Ernie Graham
032
Pete Manza @petemanza.bsky.social · 05/08/2025
New version of The Handbook of Dopamine is now online! An amazing resource. Happy to have contributed a chapter with Nora Volkow - Human dopamine systems in addiction disorders sciencedirect.com/science/arti... Huge thanks to NIAAA IRP for their support!
100
Reposted by Pete Manza
Neuropsychopharmacology @npp-journal.bsky.social · 22/07/2025
Congratulations to Dr. @petemanza.bsky.social on becoming one of the newest @acnporg.bsky.social Associate Members! 🎉 #WelcomeToACNP👋
012
Reposted by Pete Manza
Kahlert Institute for Addiction Medicine @kahlertumsom.bsky.social · 26/06/2025
Our #MeetTheMinds series is introducing the team at the Kahlert Institute for Addiction Medicine! Kynah Walston Jenkins helps keep the lab of Peter Manza, PhD, running smoothly by liaising with regulatory officials and assisting with protocol development. @petemanza.bsky.social
Graphic introducing Kynah
011
Pete Manza @petemanza.bsky.social · 25/03/2025
Our latest now out @pnas.org Huge thanks to the team (a large group of fantastic post-bacs made this possible), NIAAA, and @kahlertumsom.bsky.social for support! www.pnas.org/doi/10.1073/...
pnas.org
Neural basis for individual differences in the attention-enhancing effects of methylphenidate | PNAS
Stimulant drugs that boost dopamine, like methylphenidate (MP), enhance attention and are effective treatments for attention-deficit hyperactivity ...
053
Reposted by Pete Manza
Mary Kay Lobo @marykaylobo.bsky.social · 20/03/2025
Check out the amazing line up of speakers for the Catecholamines GRC! Apply for GRC www.grc.org/catecholamin... & GRS www.grc.org/catecholamin.... In these uncertain times we appreciate any donation to support the participants in the GRC my.grc.org/p/contributi... & GRS my.grc.org/p/contributi...
03614
Pete Manza @petemanza.bsky.social · 11/02/2025
Fantastic lineup of speakers here!!
030
Pete Manza @petemanza.bsky.social · 05/02/2025
Great new review from @renatamarchette.bsky.social on dynorphin/opioid receptor signaling and their relevance for opioid addiction treatment! rdcu.be/d8JDj
rdcu.be
The Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
044
Pete Manza @petemanza.bsky.social · 10/12/2024
Hi #ACNP2024, I'm a research fellow at NIAAA (and incoming faculty at U Maryland School of Medicine!) -- I do clinical trials paired with brain imaging to develop new therapies for addiction. Come see my poster T22 tonight!
093
Reposted by Pete Manza
Kaidi Kang @kaidikang.bsky.social · 28/11/2024
✨Our paper is out in Nature today! ✨ In this work, we investigated how we can leverage study designs to improve the replicability of brain-wide association studies (BWAS) 👇👇👇 www.nature.com/articles/s41...
nature.com
Study design features increase replicability in brain-wide association studies - Nature
Optimizing study design is critical for increasing standardized effect sizes and replicability, and the features that increase replicability in cross-sectional and longitudinal brain-wide association ...
25912
Reposted by Pete Manza
John F. Cryan @jfcryan.bsky.social · 20/11/2024
Like ‘old Twitter’: The scientific community finds a new home on Bluesky www.science.org/content/arti...
science.org
Like ‘old Twitter’: The scientific community finds a new home on Bluesky
After recent changes to Elon Musk’s X, a gradual migration turns into a stampede
07327
Reposted by Pete Manza
Katie Witkiewitz @katiew.bsky.social · 16/11/2024
We ran out of space in the first Addiction science starter pack so heres a second one! go.bsky.app/GQ31XUx
155529